The Association of Thyroid Hormone Changes with Inflammatory Status and Prognosis in COVID-19

Table 6

Univariate logistic regression analysis of parameters associated with mortality and ICU admission.

	Odds ratio (%)	Standard error	95% CI	value	Pseudo-R^2
Age (years)
Mortality	1.08	0.031	1.02–1.15	<0.001	0.14
ICU	1.06	0.016	1.02–1.09	<0.001	0.1
Length of hospitalization (days)
Mortality	1.02	0.015	1.0002–1.05	0.07	0.04
ICU	1.17	0.032	1.1–1.23	<0.001	0.38
Lymphocyte percent
Mortality	0.87	0.048	0.78–0.97	0.003	0.11
ICU	0.89	0.02	0.84–0.94	<0.001	0.12
D-dimer (mg/L)
Mortality	1.077	0.087	0.91–1.26	0.42	0.0086
ICU	2.36	0.55	1.48–3.75	<0.001	0.18
hs-CRP (mg/L)
Mortality	1.01	0.004	1.001–1.018	0.01	0.07
ICU	1.007	0.027	1.0–1.012	0.009	0.03
FT3 (ng/L)
Mortality	0.209	0.107	0.07–0.57	0.001	0.13
ICU	0.44	0.13	0.24–0.804	0.005	0.04
TSH (mU/L)
Mortality	0.36	0.21	0.11–1.14	0.03	0.06
ICU	0.46	0.13	0.26–0.805	0.001	0.06
FT4 (ng/dL)
Mortality	0.92	1.32	0.055–15.3	0.95	0.00
ICU	4.6	3.47	1.05–20.1	0.04	0.02
Ferritin (μg/L)
Mortality	1	0.001	0.99–1	0.9	0.0002
ICU	1.00	0.0003	1.00–1.001	0.03	0.02
Procalcitonin (μg/L)
Mortality	1.37	0.35	0.83–2.27	0.01	0.08
ICU	1.33	0.42	0.71–2.4	0.052	0.02

ICU: intensive care unit; LDH: lactate dehydrogenase; CRP: C-reactive protein; LDH: lactate dehydrogenase; TSH: thyroid-stimulating hormone; FT4: free thyroxine; FT3: free triiodothyronine; CI: confidence interval.